Premature Discontinuation of Contraceptive Implants
Status:
Recruiting
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
To compare rates of etonogestrel implant discontinuation in implant initiators who are given
advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen
(COCR intervention) to participants given standard counseling (comparator).
Phase:
Phase 4
Details
Lead Sponsor:
University of Colorado, Denver
Treatments:
Estradiol Ethinyl Estradiol Moxifloxacin Norgestimate Norgestimate, ethinyl estradiol drug combination